A Systematic Review on Pharmacological Interventions in Borderline Personality Disorder: Efficacy, Safety, and Management Challenges
Abstract
Background: Borderline Personality Disorder (BPD) is a complex psychiatric condition characterized by emotional instability, impulsivity, and interpersonal difficulties. Pharmacotherapy is commonly used in addition to psychotherapy to manage specific symptom domains of BPD. This systematic review aims to evaluate the safety and efficacy of pharmacological interventions in BPD.
Methods: A systematic literature search was conducted using Ovid Medline. The initial search identified 1,689 papers, which were screened based on relevance to the topic, resulting in 12 studies that met the inclusion criteria. The final 12 articles were grouped into three overarching themes: the efficacy of antipsychotics, the effectiveness of non-antipsychotic treatments, and challenges in pharmacological management.
Results: The review revealed mixed outcomes for pharmacotherapy in BPD. Antipsychotics showed some efficacy in reducing emotional dysregulation and impulsivity, though side effects were noted. Non-antipsychotic treatments, including lamotrigine, showed limited efficacy, while ketamine showed potential effectiveness for refractory cases. Challenges in pharmacological management were prominent.
Discussion: Pharmacotherapy can play a role in symptom management for BPD, especially for severe cases unresponsive to psychotherapy alone. However, the evidence remains inconsistent, and no medication has demonstrated comprehensive efficacy across all symptom domains.
Conclusion: Pharmacological…
How strong is the evidence?
Evidence Hub reads this as a systematic review. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- The neurocircuitry of addiction: an overview
- Gender Differences in Human Brain: A Review
- Stratified medicine for mental disorders
- The neurobiology of drug addiction: cross-species insights into the dysfunction and recovery of the prefrontal cortex
- Annual Research Review: DNA methylation as a mediator in the association between risk exposure and child and adolescent psychopathology
- Schizophrenia: The new etiological synthesis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.